A Pfizer and Cytel veteran on why statisticians belong at trial design, and why fewer sponsors keep them in-house.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
ON-DEMAND WEBINARS
See how digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial were endorsed by the FDA, marking an important milestone.
Experts from diverse industry sectors unpack key points from the FDA’s final guidance on Digital Health Technologies (DHT) for remote data collection in clinical investigations.
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![mobile-app-clinical-trials-GettyImages-1321691686]( "Putting Clinical Trial Needs Right In Patients' Pockets")
Putting Clinical Trial Needs Right In Patients' PocketsManaging study tasks across multiple tools increases burden for participants. A unified mobile experience simplifies workflows, reduces mental load, and helps patients stay engaged.
-
![doctor meeting clinical iStock-846002754]( "Bridging Clinical Efficacy And Real-World Effectiveness In Digital Therapeutics Trials")
Bridging Clinical Efficacy And Real-World Effectiveness In Digital Therapeutics TrialsNo matter how conclusive clinical evidence is for medical treatments, developers may struggle to see precisely how their treatment performs in the real world—outside the controlled environment of the clinic or office.
-
![GettyImages-1189687523 AI]( "The Pharmaceutical Industry: 2024 (And Beyond) Predictions")
The Pharmaceutical Industry: 2024 (And Beyond) PredictionsDCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
![GettyImages-1137736725 data platform]( "The Power Of Site Enablement Platforms As An Insurance Policy")
The Power Of Site Enablement Platforms As An Insurance PolicyDelve into the pivotal role played by this Site Enablement Platform in upholding business continuity for clinical trials.
-
![GettyImages-1180780708 health]( "Benefits Of Implementing EDC & Medical Coding With RTSM")
Benefits Of Implementing EDC & Medical Coding With RTSMDiscover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
![GettyImages-2210195887-tablet-phone-recruitment]( "How To Reduce Eligibility Risk And Prevent Protocol Deviations")
How To Reduce Eligibility Risk And Prevent Protocol DeviationsEliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "EDC Powers End-To-End Data Management In Pharma-Sponsored Trials")
EDC Powers End-To-End Data Management In Pharma-Sponsored TrialsAs clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
![protocol-design-clinical-GettyImages-2215940332]( "Real-Time Trials Need Real-Time Data You Can Trust")
Real-Time Trials Need Real-Time Data You Can TrustThe FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.
-
![clinical-trials-patients-GettyImages-1629549075]( "When Early CRO Wins Quietly Create Long-Term Study Risk")
When Early CRO Wins Quietly Create Long-Term Study RiskDiscover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
-
![ecoa-regulatory-GettyImages-2159342566]( "Paper COAs in 2026: It's Not Cheaper, It's Riskier")
Paper COAs in 2026: It's Not Cheaper, It's RiskierLearn why sticking with paper records is a faulty strategy and discover how hidden costs, transcription errors, and regulatory red flags make digital COAs the only safe choice for modern trials.
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
